Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Alzheimer's, type 2 diabetes
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Ozempic, Wegovy may lower Alzheimer’s risk in people with diabetes
Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for Alzheimer’s disease, a new study shows.
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.
4h
on MSN
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist ...
6h
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Alzheimer's disease
Food and Drug Administration
Novo Nordisk
Wegovy
Semaglutide
Feedback